Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432,001,939
-
Total 13F shares
-
226,132,987
-
Share change
-
+38,886,110
-
Total reported value
-
$11,317,812,164
-
Put/Call ratio
-
228%
-
Price per share
-
$50.05
-
Number of holders
-
188
-
Value change
-
+$1,961,711,795
-
Number of buys
-
146
-
Number of sells
-
48
Institutional Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q4 2020
As of 31 Dec 2020,
Royalty Pharma plc - Common Stock (RPRX) was held by
188 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
226,132,987 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, MORGAN STANLEY, Vantage Consulting Group Inc, Capital International Investors, HARVARD MANAGEMENT CO INC, BlackRock Inc., SIGULER GUFF ADVISERS, LLC, JPMORGAN CHASE & CO, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
188
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.